(Q24234791)

2

0 references

Michael Marrone

3

0 references

Yassine Daoud

4

0 references

Walter J Stark

5

0 references

Thomas Heflin

6

0 references

Andrea Zambrano

7

0 references

Li Tang

8

0 references

Manuel Datiles

9

0 references

Esen K Akpek

Cochrane Database of Systematic Reviews

10

0 references

publication date

7 September 2011

0 references

published in

0 references

cites work

The pathology of dry eye.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

Dysfunctional tear syndrome: a Delphi approach to treatment recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

Serum growth factor analysis in dry eye syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

A comparison of faces scales for the measurement of pediatric pain: children's and parents' ratings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

Rationale for anti-inflammatory therapy in dry eye syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

Senile atrophy of the human lacrimal gland: the contribution of chronic inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

Pharmacotherapy of dry eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

A patient questionnaire approach to estimating the prevalence of dry eye symptoms in patients presenting to optometric practices across Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

Punctal occlusion for dry eye syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

The evolving treatment of dry eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

Sjögren's syndrome in dermatology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

Autologous serum eye drops for ocular surface disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

Topical fibronectin ophthalmic solution in the treatment of persistent defects of the corneal epithelium. Chiron Vision Fibronectin Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

Growth factors: importance in wound healing and maintenance of transparency of the cornea

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

Autologous serum eye drops for the treatment of dry eye diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

A protocol for low contamination risk of autologous serum drops in the management of ocular surface disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

Autologous serum in the management of recalcitrant dry eye syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

Correlation of the Schirmer 1 and fluorescein clearance tests with the severity of corneal epithelial and eyelid disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

Autologous serum application in the treatment of neurotrophic keratopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

The epidemiology of dry eye in Melbourne, Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

Topical fibronectin therapy in persistent corneal ulceration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

Immunoglobulin deposition in the cornea after application of autologous serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

The repeatability of clinical measurements of dry eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

Fibronectin. A new therapy for corneal trophic ulcer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

Dry eye diagnosis and management in 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

Antiinflammatory therapy for dry eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

Autologous serum eyedrops for dry eyes and epithelial defects: clinical and in vitro toxicity studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

Autologous serum for ocular surface diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

The role of the lacrimal functional unit in the pathophysiology of dry eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The Cyclosporin A Phase 2 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

Androgen deficiency, Meibomian gland dysfunction, and evaporative dry eye

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

Controlled study of the use of autologous serum in dry eye patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

Corneal and conjunctival sensitivity in patients with dry eye: the effect of topical cyclosporine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

Treatment of dry eye by autologous serum application in Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

Serum application for the treatment of ocular surface disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

Test results in patients with Sjögren's syndrome defined by the Japanese criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

Management of Ocular Surface Inflammation in Sjögren Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

Clinical Experience With a Mobile Ocular Perfusion Pump

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

7 January 2021

Ocular surface changes and discomfort in patients with meibomian gland dysfunction

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

7 January 2021

Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

7 January 2021

Synergistic effects of substance P with insulin-like growth factor-1 on epithelial migration of the cornea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

7 January 2021

[Legal regulations to produce serum eye drops : when is it necessary, and how can it be obtained?]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

7 January 2021

An optimised protocol for the production of autologous serum eyedrops

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

7 January 2021

Physiological concentrations of human epidermal growth factor in biological fluids: use of a sensitive enzyme immunoassay

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

7 January 2021

Comparison of autologous serum and umbilical cord serum eye drops for dry eye syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

7 January 2021

Topical fibronectin in the treatment of keratoconjunctivitis sicca. Chiron Keratoconjunctivitis Sicca Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

7 January 2021

Topical fibronectin in the treatment of persistent corneal epithelial defects and trophic ulcers

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

7 January 2021

Corneal sensitivity after photorefractive keratectomy.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

7 January 2021

Ocular evaporation in meibomian gland dysfunction and dry eye

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

7 January 2021

The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

7 January 2021

GVHD dry eyes treated with autologous serum tears

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

7 January 2021

Allogeneic serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

7 January 2021

Ocular complications of systemic medications

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

7 January 2021

Low-cost protocol for the production of autologous serum eye drops by blood collection and processing centres for the treatment of ocular surface diseases

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

7 January 2021

[Topical amniotic fluid: a potential new alternative for ocular surface diseases]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327

7 January 2021

10.1002/14651858.CD009327

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

2190590

Fatcat ID

release_eldr3nyhgzepff6mv3h7duikai

0 references

OpenCitations bibliographic resource ID

2190590

1 reference